Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Copenhagen University
- License Information
-
More Information
Article History
Received: 22 May 2025
Accepted: 2 January 2026
First Online: 24 March 2026
Declarations
:
: Genetic analysis, blood sample analysis, DXA, and X-ray evaluation were performed during clinical diagnostic investigations. The research was conducted in accordance with the ethical standards.
: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: Informed consent was obtained from the subjects to publish their data.
: EAS has nothing to disclose. NH received research funding from Alexion and AstraZeneca Rare Disease and lecturer fees from Gedeon Richter and UCB. JEBJ is a board member in Eli Lilly, Amgen, and UCB. JEBJ received funding from Eli Lilly, Novo Nordic, and Amgen and consulting fees from UCB, Giliad, Amgen, GSK, Utsaka, and Abbvie.
